Yussf Nafisa, Wallace Jack, Perrier Meg, Romero Nicole, Cowie Benjamin, Allard Nicole
WHO Collaborating Centre for Viral Hepatitis, Doherty Institute for Infection and Immunity, Melbourne, Vic. 3000, Australia; and Department of Infectious Diseases, University of Melbourne, Melbourne, Vic. 3000, Australia.
Burnet Institute, Melbourne, Vic. 3004, Australia.
Aust J Prim Health. 2022 Dec;28(6):514-521. doi: 10.1071/PY22014.
Mother-to-child transmission (MTCT) of hepatitis B can be prevented with targeted interventions; however, MTCT continues to occur in Australia and globally. This qualitative research investigated how mothers with chronic hepatitis B (CHB) understand and experience interventions for the prevention of MTCT of CHB (PMTCT-CHB) in Victoria, Australia.
Semi-structured interviews were conducted with women with CHB. Participants were recruited through purposive and snowballing sampling. Interviews explored the women's experience of care for themselves and their infants aimed at PMTCT-CHB. Interviews were conducted over the phone with a qualified interpreter where required. The consolidated criteria for reporting qualitative research framework was used with data thematically analysed. This study was co-designed with mothers with CHB through a Community Advisory Group established for this research; coordinated and supported by LiverWELL and the researchers.
Sixteen women were interviewed. Although most women understood the purpose of hepatitis B vaccination, there were significant gaps in information and education provided to mothers regarding PMTCT-CHB. These gaps included understanding of the extent of protection of vaccination, breastfeeding with CHB, post-vaccination testing for infants and lack of clarity of the woman's own hepatitis B status. There was notable fear and worry associated with hepatitis B transmission, with emotional support for mothers identified as a major gap in service delivery. Additionally, some women experienced stigma and discrimination due to their hepatitis B and refugee status.
This study explored how mothers with CHB understand and experience interventions to prevent MTCT. Our findings reveal substantial gaps in delivery of information and care in the context of PMTCT-CHB in Victoria. Our findings can support development of evidence-based interventions and systems to improve healthcare for mothers with CHB and their infants, and thereby reduce possible CHB transmission and other negative outcomes, including stigma and discrimination.
通过有针对性的干预措施可预防乙型肝炎的母婴传播(MTCT);然而,在澳大利亚乃至全球,MTCT仍在发生。这项定性研究调查了患有慢性乙型肝炎(CHB)的母亲如何理解并体验澳大利亚维多利亚州预防CHB母婴传播(PMTCT-CHB)的干预措施。
对患有CHB的女性进行了半结构化访谈。通过立意抽样和滚雪球抽样招募参与者。访谈探讨了这些女性为预防PMTCT-CHB而接受的自我及婴儿护理体验。必要时通过电话与合格口译员进行访谈。采用定性研究报告的统一标准框架对数据进行主题分析。本研究通过为此项研究设立的社区咨询小组与患有CHB的母亲共同设计;由LiverWELL和研究人员协调并提供支持。
对16名女性进行了访谈。尽管大多数女性了解乙型肝炎疫苗接种的目的,但在向母亲提供的有关PMTCT-CHB的信息和教育方面仍存在重大差距。这些差距包括对疫苗接种保护程度的理解、患有CHB时的母乳喂养、婴儿接种疫苗后的检测,以及女性自身乙型肝炎状况不明确。与乙型肝炎传播相关的恐惧和担忧较为明显,为母亲提供情感支持被认为是服务提供方面的一个主要差距。此外,一些女性因其乙型肝炎和难民身份而遭受耻辱和歧视。
本研究探讨了患有CHB的母亲如何理解并体验预防MTCT的干预措施。我们的研究结果揭示了维多利亚州在PMTCT-CHB背景下信息和护理提供方面存在的重大差距。我们的研究结果可支持制定基于证据的干预措施和系统,以改善对患有CHB的母亲及其婴儿的医疗保健,从而减少可能的CHB传播及其他负面后果,包括耻辱和歧视。